JavaScript is
disabled!
Please enable to improve your experience.
THIS IS AN ADVERTISEMENT
health care
uninterrupted.
Hall Render Advisory Services
COVID-19 Resources
MENU
About Us
Inclusion & Belonging Overview
Recognition
Firm Leadership
Services
Our People
Attorneys
Consultants
Administrative Team
Offices
Anchorage Office
Dallas Office
Denver Office
Detroit Office
Indianapolis Office
Milwaukee Office
Raleigh Office
Washington, D.C. Office
Resources
Articles
Firm News
Webinars
Presentations
Podcasts
Careers
Contact
MENU
Search
About Us
Inclusion & Belonging Overview
Recognition
Firm Leadership
Services
Our People
Attorneys
Consultants
Administrative Team
Offices
[Column]
[Column]
[Column]
[Column]
Resources
Articles
Firm News
Webinars
Presentations
Podcasts
Careers
Contact
Hall Render Advisory Services
COVID-19 Resources
Resources
Articles related to Virtual Care
< back to service
Medicare’s Telehealth Proposals for CY 2026
[07/16/25]
OIG Issues Favorable Advisory Opinion Regarding Telehealth Platform Arrangements
[07/02/25]
Telehealth March Madness: Medicare Waivers Extended While DEA Rules Get Benched
[03/26/25]
DEA Publishes Long-Awaited Rules for Telemedicine Prescribing
[01/22/25]
Congress Passes Extension to Key Telehealth Payment Policies
[12/24/24]
DEA and HHS Announce Third Extension of COVID-Era Telemedicine Flexibilities for Controlled Substance Prescribing
[11/20/24]
DEA and HHS Extend COVID-19 Telemedicine Flexibilities for Controlled Medications Prescriptions Again
[10/12/23]
Fall Forecast: Upcoming Telehealth Controlled Substance Rule
[09/15/23]
Federal Court of Appeals Panel Issues Ruling in Litigation Challenging FDA Approval of Mifepristone
[08/31/23]
DEA & SAMHSA Issue Temporary Rule Extending COVID-19 Telemedicine Flexibilities for Controlled Substances Prescribing Beyond the Termination of COVID-19 PHE
[05/09/23]
DEA Proposes New Rules that Would Permanently Allow for Telemedicine Controlled Substance Prescriptions
[02/27/23]
FDA Expands Access to Mifepristone: Next Steps for Providers and Retail Pharmacies
[02/07/23]
Medicare Physician Fee Schedule for 2023: What Providers Need to Know
[12/30/22]
DOJ & OIG Ramp Up Enforcement and Oversight to Combat Telemedicine Fraud
[09/15/22]
Medicare Telehealth Update for CY 2022
[11/10/21]
FCC Announces Details on Round 2 of COVID-19 Telehealth Program Following Public Comment
[04/07/21]
The Future of Telehealth: Examining “What’s Next”
[03/16/21]
OIG Leadership Discusses Its 2021 Plan to Assess Telehealth Services
[03/02/21]
Congress Appropriated Nearly $250 Million in Additional Funds to FCC’s COVID-19 Telehealth Program; FCC Seeks Comment
[01/19/21]
HHS Modifies PREP Act Declaration to Expand Telehealth
[12/04/20]
Telehealth Boom Continues: CMS Adds New Covered Services
[10/16/20]
Telehealth – Considerations for Credentialing and Clinical Privileging
[08/06/20]
Telehealth Expansion: Proposed 2021 Physician Fee Schedule Updates and Planning for the New Normal
[08/04/20]
Provision of Telehealth Equipment: Updated COVID-19 Guidance
[05/13/20]
CMS Expands Upon Prior Telehealth Waivers as Part of COVID-19 Response
[05/01/20]
CMS Telehealth Expansion for RHCs and FQHCs
[04/20/20]
CMS Confirms Provider’s Home Acceptable for Distant Site Telehealth Services
[03/24/20]
Indiana Medicaid Temporarily Expands Telehealth Coverage in Response to COVID-19
[03/20/20]
Medicare Telehealth Waivers Now Implemented with Significant Expansion
[03/17/20]
COVID-19 Results in Removal of DEA Controlled Substance Prescribing Limitations for Telemedicine
[03/17/20]
Congress Once Again Trying to CONNECT on Telehealth
[11/06/19]
FCC Proceeds with $100 Million Telehealth Initiative, Seeks Comments on Proposed Program Rules
[08/06/19]
Additional Telehealth Benefits Coming to Medicare Advantage in 2020
[07/12/19]
Consider Website and Other Technology Accessibility Obligations to Better Serve Your Community and Avoid Litigation and Loss of Federal Funding
[03/01/19]
Resources
Webinars
Presentations
Articles and Webinars
Sign up to receive health care industry news.